Unusual neurotoxic envenomations byVipera aspis aspis snakes in France
- 1 March 2002
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 21 (3) , 137-145
- https://doi.org/10.1191/0960327102ht226oa
Abstract
Vipera aspis aspis (V.a.a.) is the most dangerous poisonous snake in South-Eastern France. The clinical symptoms observed after V.a.a. envenomations involve mostly local signs (pain, edema) associated in the more severe cases with systemic symptoms (gastro-intestinal and cardiovascular manifestations). Since 1992, several unusual cases of moderate and severe `neurotoxic’ envenomations by V.a.a. snakes have been reported in a very localized area in South-Eastern France. Most of the human patients mainly suffered neurological signs owing to cephalic muscle paralysis. Drowsiness and dyspnea were observed for the most severe cases. Envenomed animals suffered respiratory distress and paralysis. The local signs were never as severe as observed after envenomations by vipers in other French regions. Human patients with moderate or severe clinical features received two intravenous injections of Viperfav2 antivenom, the first dose inducing the decrease of the neurological signs and the second reducing significantly the edema. Neurotoxic components immunologically cross-reacting with toxins from V. ammodytes ammodytes venom from Eastern Europe were detected in the blood of all patients suffering neurological symptoms after a V.a.a. bite. The protective efficacy of various antivenoms was evaluated in mice. The existence of geographical variations in the composition of V.a.a. venom emphasizes on the use of polyvalent antivenom in the treatment of viper envenomations in France. Human & Experimental Toxicology (2002) 21, 137 – 145.Keywords
This publication has 15 references indexed in Scilit:
- Biological and biochemical activities of Vipera berus (European viper) venomToxicon, 1993
- Isolation and characterization of procoagulant from the venom of vipera aspis aspisInternational Journal of Biochemistry, 1993
- Envenoming by viper bites in France: Clinical gradation and biological quantification by ELISAToxicon, 1992
- Neuromuscular paralysis in vipera aspis envenomation: pathogenetic mechanisms.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Snake venom variability: methods of study, results and interpretationToxicon, 1991
- Purification and physiological study of a hypotensive factor from the venom of Vipera aspis aspis (aspic viper)Toxicon, 1990
- Neutralization of lethal potency and inhibition of enzymatic activity of a phospholipase A2 neurotoxin, crotxin, by non‐precipitating antibodies (Fab)FEBS Letters, 1989
- Sequence Homology between Phospholipase and its Inhibitor in Snake Venom. The Primary Structure of Phospholipase A2of Vipoxin from the Venom of the Bulgarian Viper (Vipera ammodytes ammodytes,Serpentes)Biological Chemistry Hoppe-Seyler, 1987
- Ammodytoxin A, a highly lethal phospholipase A2 from Vipera ammodytes ammodytes venomBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Biochemistry and Pharmacology of the Crotoxin ComplexEuropean Journal of Biochemistry, 1974